appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Camlin Fine Sciences Ltd
CAMLINFINE
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Camlin Fine Sciences Limited is engaged in fine chemicals business. It provides antioxidants and shelf life extensions, aroma ingredients, performance chemical products and related solutions various industries.
Investor PresentationView older
View Older PresentationsPeersCompare with peers
Gujarat Fluorochemicals Ltd
Navin Fluorine International Ltd
Vinati Organics Ltd
Aarti Industries Ltd
Clean Science and Technology Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Decreased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has decreased by 1.25%
Recent NewsAll news
Camlin Fine Sciences allots 14,750 equity shares under ESOP
1 week ago•Business Standard
Camlin Fine Sciences Q3 Results Review - Operational Performance Below Expectation: Nirmal Bang
1 month ago•Bloomberg Quint
Camlin Fine Sciences consolidated net profit declines 16.30% in the December 2022 quarter
1 month ago•Business Standard
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant